ASCO 2025 presented studies on AI-driven risk prediction and targeted therapies in cancer care.
THE American Society of Clinical Oncology (ASCO) 2025 Annual Meeting spotlighted groundbreaking advancements across cancer prevention, treatment, and supportive care. From developments in AI-driven risk prediction and targeted therapies to innovative digital tools supporting precision medicine, quality of life, and individualized care. Below are some of the most impactful studies presented at the meeting.
No takes yet. Share an insight, caveat, or question.
European Medical Journal (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: